相关实验视频
Updated: Jul 1, 2026

08:01
The Soft Agar Colony Formation Assay
Published on: October 27, 2014
FBXW7针对mTOR进行降解,并与PTEN合作抑制瘤
Jian-Hua Mao1, Il-Jin Kim, Di Wu
1Cancer Research Institute, University of California at San Francisco, 2340 Sutter Street, San Francisco, CA 94143, USA.
概括
瘤抑制剂FBXW7针对哺乳动物的拉帕素 (mTOR) 向降解. 癌细胞中FBXW7的丧失表明对mTOR通路抑制剂 (如拉巴胺) 的敏感性.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 拉巴素 (mTOR) 途径的哺乳动物点在细胞生长中至关重要,也是癌症治疗的关键点.
- 了解mTOR蛋白水平的调节对于开发有效的癌症治疗至关重要.
- 瘤抑制蛋白在控制mTOR活动中的作用在很大程度上仍未被探索.
研究的目的:
- 阐明控制哺乳动物目标拉巴素 (mTOR) 蛋白水平的调控机制.
- 在癌症的背景下研究FBXW7和mTOR之间的相互作用.
- 为了确定潜在的生物标志物来预测对mTOR向治疗的反应.
主要方法:
- 乌比基化试验检测mTOR修饰的情况.
- 蛋白质降解研究以评估mTOR稳定性.
- 分析人类乳腺癌细胞系和原发性瘤的FBXW7和PTEN状态.
- 使用拉巴胺治疗对具有FBXW7突变的瘤细胞系的灵敏度测试.
主要成果:
- 瘤抑制剂FBXW7直接针对mTOR进行无处不在和随后的降解.
- 在人类乳腺癌中观察到FBXW7损失和PTEN缺失/突变之间的相互关系.
- 患有FBXW7缺失或突变的瘤细胞系对拉帕米辛的敏感性增加.
结论:
- FBXW7通过有针对性的降解,作为mTOR蛋白水平的负调节剂.
- 丢失FBXW7,通常与PTEN变化同时发生,识别了易受mTOR通路抑制的癌症.
- 在癌症治疗中,FBXW7状态可以作为拉巴素和其他mTOR抑制剂治疗的预测生物标志物.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
